Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3838
Gene Symbol: KPNA2
KPNA2
0.010 AlteredExpression group BEFREE KPNA2 expression is associated with carcinogenesis of IPMN through the adenoma-carcinoma sequence. 28476582 2019
Entrez Id: 3791
Gene Symbol: KDR
KDR
0.010 Biomarker group BEFREE Protein expression analysis revealed that the vascular endothelial growth factor receptor 2 (VEGFR2) score was significantly higher in the sestamibi-positive cohort compared to sestamibi-negative adenomas (P = .038). 31291025 2019
Entrez Id: 2346
Gene Symbol: FOLH1
FOLH1
0.010 AlteredExpression group BEFREE <b>Methods:</b> PSMA protein expression in tissue samples from 50 ACCs, 90 ACAs (including 20 from patients who presented with Cushing's syndrome, 20 aldosterone-producing adenomas and 50 non-functional tumors) and 10 tissues that were metastases from other primary sites was assessed by immunohistochemistry. 31040822 2019
Entrez Id: 7855
Gene Symbol: FZD5
FZD5
0.010 Biomarker group BEFREE Pharmacologic targeting of Fzd inhibited the growth of gastric adenomas <i>in vivo</i>. 30622113 2019
Entrez Id: 652995
Gene Symbol: UCA1
UCA1
0.010 AlteredExpression group BEFREE Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). 31694571 2019
Entrez Id: 4913
Gene Symbol: NTHL1
NTHL1
0.010 GeneticVariation group BEFREE In four of the probands the adenoma susceptibility could be explained by actionable mutations in APC or MUTYH, and one other patient was a double carrier of two truncating variants in both POLE and NTHL1. 31285513 2019
Entrez Id: 643911
Gene Symbol: CRNDE
CRNDE
0.010 AlteredExpression group BEFREE LncRNAs are promising candidates as they are involved in carcinogenesis, and certain lncRNAs (<i>e.g</i>., CCAT1, CRNDE, CRCAL1-4) show altered expression in adenomas, making them potential early diagnostic markers. 31558855 2019
Entrez Id: 406953
Gene Symbol: MIR18A
MIR18A
0.010 Biomarker group BEFREE We identified and validated a signature of 6 miRNAs (miRNA19a, miRNA19b, miRNA15b, miRNA29a, miRNA335, and miRNA18a) as predictors that can differentiate significantly patients with CRC and AA from those who are healthy. 30702491 2019
Entrez Id: 3159
Gene Symbol: HMGA1
HMGA1
0.010 AlteredExpression group BEFREE Interestingly, the HMGA1 and HMGA2 nuclear expression levels were significantly higher in invasive adenomas than in noninvasive adenomas. 30999005 2019
Entrez Id: 948
Gene Symbol: CD36
CD36
0.010 AlteredExpression group BEFREE Here, we discover that CD36 expression is progressively decreased from adenomas to carcinomas. 31484922 2019
Entrez Id: 9970
Gene Symbol: NR1I3
NR1I3
0.010 GeneticVariation group BEFREE Eight- to fifteen-year-old dogs with carcinoma (CAR Group; N=5), epithelioma (EPI Group; N=16) or adenoma (ADE Group; N=24) were used. 31028190 2019
Entrez Id: 9965
Gene Symbol: FGF19
FGF19
0.010 AlteredExpression group BEFREE Lipid levels and body mass index values strongly correlated with FGF19 and FGFR4 levels in patients with colon adenomas. 30517925 2019
Entrez Id: 5792
Gene Symbol: PTPRF
PTPRF
0.010 AlteredExpression group BEFREE We discussed the 2 published cases and describe another case of poorly-differentiated plurihormonal PIT-1 positive adenoma with moderate SSTR2 expression and intense STTR5 expression succeffuly treated with PAS-LAR 40mg/month. 31167164 2019
Entrez Id: 1540
Gene Symbol: CYLD
CYLD
0.010 Biomarker group BEFREE We assess the recurrence of rectal adenomas operated using TEM with full-thickness wall excision with or without free resection margins and define optimal endoscopic follow-up. 30306452 2019
Entrez Id: 2551
Gene Symbol: GABPA
GABPA
0.010 Biomarker group BEFREE Nrf2 is gradually increasing from normal mucosa to adenoma and was highest in carcinoma but was not associated with features of tumor invasiveness. 30597358 2019
Entrez Id: 407
Gene Symbol: ARR3
ARR3
0.010 GeneticVariation group BEFREE Eight- to fifteen-year-old dogs with carcinoma (CAR Group; N=5), epithelioma (EPI Group; N=16) or adenoma (ADE Group; N=24) were used. 31028190 2019
Entrez Id: 7035
Gene Symbol: TFPI
TFPI
0.010 GeneticVariation group BEFREE Eight- to fifteen-year-old dogs with carcinoma (CAR Group; N=5), epithelioma (EPI Group; N=16) or adenoma (ADE Group; N=24) were used. 31028190 2019
Entrez Id: 100507056
Gene Symbol: CCAT1
CCAT1
0.010 AlteredExpression group BEFREE LncRNAs are promising candidates as they are involved in carcinogenesis, and certain lncRNAs (<i>e.g</i>., CCAT1, CRNDE, CRCAL1-4) show altered expression in adenomas, making them potential early diagnostic markers. 31558855 2019
Entrez Id: 571
Gene Symbol: BACH1
BACH1
0.010 AlteredExpression group BEFREE The mean of Bach1 expression was highest in apparently normal colonic mucosa (267 ± 16), lowest in adenoma (53 ± 31) and high in carcinoma tissues (194 ± 93). 30597358 2019
Entrez Id: 64102
Gene Symbol: TNMD
TNMD
0.010 Biomarker group BEFREE We assess the recurrence of rectal adenomas operated using TEM with full-thickness wall excision with or without free resection margins and define optimal endoscopic follow-up. 30306452 2019
Entrez Id: 158506
Gene Symbol: CBLL2
CBLL2
0.010 GeneticVariation group BEFREE The E3 ubiquitin ligase ring finger protein 43 (RNF43) is frequently mutated in gastric tumors and loss of RNF43 expression was suggested to be one of the key events during the transition from adenoma to gastric carcinoma. 30884828 2019
Entrez Id: 8321
Gene Symbol: FZD1
FZD1
0.010 Biomarker group BEFREE Pharmacologic targeting of Fzd inhibited the growth of gastric adenomas <i>in vivo</i>. 30622113 2019
Entrez Id: 6364
Gene Symbol: CCL20
CCL20
0.010 Biomarker group BEFREE We found 14 markers associated with risk of adenoma overall; three of these were also associated with incident adenoma: CC-chemokine cysteine motif chemokine ligand 20 (CCL20) [overall adenoma fourth versus first quartile: OR 4.8, 95% CI 2.0-12, Ptrend 0.0007; incident adenoma third versus first tertile: OR 4.6, 95% CI 1.0-22, Ptrend 0.03], growth-related gene oncogene products (GRO) [OR 3.8, 95% CI 1.6-9.3, Ptrend 0.006 and OR 3.6, 95% CI 1.1-12, Ptrend 0.04, respectively] and insulin [OR 2.9, 95% CI 0.8-10, Ptrend 0.05 and OR 7.8, 95% CI 1.3-46, Ptrend 0.03, respectively].All statistical tests were two-sided. 30753331 2019
Entrez Id: 6352
Gene Symbol: CCL5
CCL5
0.010 GeneticVariation group BEFREE We identified that tumor-derived cytokine CCL5 is upregulated in AIP-mutation-positive human adenomas. 30867568 2019
Entrez Id: 6687
Gene Symbol: SPG7
SPG7
0.010 GeneticVariation group BEFREE Eight- to fifteen-year-old dogs with carcinoma (CAR Group; N=5), epithelioma (EPI Group; N=16) or adenoma (ADE Group; N=24) were used. 31028190 2019